SEC Comment Letter for Altimmune, Inc. (ALT) (CIK 0001326190) (ALT) — May 15, 2008

Altimmune, Inc. (ALT) (CIK 0001326190)
Date: May 15, 2008 · CIK: 0001326190 · Accession: 0000000000-08-024960

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-32587

Date

May 15, 2008

Author

Jeffrey Riedler

Form

UPLOAD

Company

Altimmune, Inc. (ALT) (CIK 0001326190)

Letter

Mail Stop 6010 May 15, 2008 Mr. Christopher C. Camut Chief Financial Officer and Secretary PharmAthene, Inc. One Park Place, Suite 450 Annapolis, MD 21401 Re: PharmAthene, Inc. Preliminary Proxy Statement on Schedule 14A Filed on April 29, 2008 File Number 001-32587 Dear Mr. Camut:

We have completed our review of your proxy statement and have no further comments at this time. Please contact Sonia Barros at (202) 551-3655 with any questions. S i n c e r e l y , J e f f r e y R i e d l e r A s s i s t a n t D i r e c t o r cc: Jeffrey A. Baumel, Esq. Sonnenschein Nath & Rosenthal LLP 101 JFK Parkway Short Hills, NJ 07078

Show Raw Text

Mail Stop 6010         May 15, 2008  Mr. Christopher C. Camut Chief Financial Officer and Secretary PharmAthene, Inc. One Park Place, Suite 450 Annapolis, MD 21401
Re: PharmAthene, Inc.
  Preliminary Proxy Statement on Schedule 14A
  Filed on April 29, 2008   File Number 001-32587
Dear Mr. Camut:

We have completed our review of your proxy statement and have no further comments at
this time.  Please contact Sonia Barros at (202) 551-3655 with any questions.         S i n c e r e l y ,            J e f f r e y  R i e d l e r         A s s i s t a n t  D i r e c t o r   cc: Jeffrey A. Baumel, Esq.
Sonnenschein Nath & Rosenthal LLP 101 JFK Parkway Short Hills, NJ 07078

SecProbe.io